AQUILON PHARMACEUTICALS

Activaero

The company develops controlled breathing systems and smart nebulisers to deliver inhaled drugs for patients with severe respiratory diseases.

Softhale

This company develops propellant-free soft mist inhaler devices and pharmaceutical products for patients suffering from asthma and chronic obstructive pulmonary disease.

AirNexis Therapeutics

This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.

Avalyn Pharma

The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.

Aer Therapeutics

This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.

Verona Pharma

This biopharmaceutical company develops and commercialises inhaled medicines to treat chronic respiratory diseases for adult patients with conditions such as chronic obstructive pulmonary disease.

Nebu-Flow

The company develops nebuliser technology for pharmaceutical partners to deliver biologic drugs and other formulations to the lungs of patients with respiratory disorders.

Aiolos Bio

This biopharmaceutical company develops monoclonal antibody therapies for patients suffering from respiratory and inflammatory conditions such as moderate-to-severe asthma.